AMG National Trust Bank Has $320,000 Stock Position in Agilent Technologies, Inc. (NYSE:A)

AMG National Trust Bank lifted its position in shares of Agilent Technologies, Inc. (NYSE:AGet Rating) by 9.5% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,629 shares of the medical research company’s stock after buying an additional 229 shares during the quarter. AMG National Trust Bank’s holdings in Agilent Technologies were worth $320,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of A. Massachusetts Financial Services Co. MA raised its stake in Agilent Technologies by 42.2% in the second quarter. Massachusetts Financial Services Co. MA now owns 5,851,153 shares of the medical research company’s stock valued at $694,942,000 after purchasing an additional 1,736,168 shares in the last quarter. Principal Financial Group Inc. grew its position in Agilent Technologies by 62.4% in the second quarter. Principal Financial Group Inc. now owns 3,115,931 shares of the medical research company’s stock valued at $370,078,000 after acquiring an additional 1,197,836 shares during the last quarter. Goldman Sachs Group Inc. grew its position in Agilent Technologies by 67.6% in the first quarter. Goldman Sachs Group Inc. now owns 2,336,607 shares of the medical research company’s stock valued at $309,203,000 after acquiring an additional 942,651 shares during the last quarter. Renaissance Technologies LLC grew its position in Agilent Technologies by 196.4% in the first quarter. Renaissance Technologies LLC now owns 1,242,600 shares of the medical research company’s stock valued at $164,433,000 after acquiring an additional 823,300 shares during the last quarter. Finally, Point72 Asset Management L.P. grew its position in Agilent Technologies by 564.2% in the second quarter. Point72 Asset Management L.P. now owns 781,924 shares of the medical research company’s stock valued at $92,869,000 after acquiring an additional 664,198 shares during the last quarter.

Insiders Place Their Bets

In other news, VP Padraig Mcdonnell sold 672 shares of the stock in a transaction that occurred on Tuesday, December 13th. The shares were sold at an average price of $160.00, for a total transaction of $107,520.00. Following the completion of the transaction, the vice president now directly owns 15,529 shares of the company’s stock, valued at approximately $2,484,640. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, SVP Henrik Ancher-Jensen sold 29,500 shares of the company’s stock in a transaction that occurred on Wednesday, December 14th. The shares were sold at an average price of $155.78, for a total transaction of $4,595,510.00. Following the sale, the senior vice president now directly owns 70,793 shares in the company, valued at approximately $11,028,133.54. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, VP Padraig Mcdonnell sold 672 shares of the company’s stock in a transaction that occurred on Tuesday, December 13th. The shares were sold at an average price of $160.00, for a total transaction of $107,520.00. Following the sale, the vice president now owns 15,529 shares in the company, valued at $2,484,640. The disclosure for this sale can be found here. In the last ninety days, insiders sold 209,039 shares of company stock valued at $32,268,881.

Agilent Technologies Trading Down 2.1 %

A opened at $155.69 on Wednesday. The company has a debt-to-equity ratio of 0.52, a current ratio of 2.03 and a quick ratio of 1.47. Agilent Technologies, Inc. has a fifty-two week low of $112.52 and a fifty-two week high of $160.26. The firm has a market capitalization of $46.10 billion, a PE ratio of 37.34, a P/E/G ratio of 2.76 and a beta of 1.07. The company’s 50-day moving average is $152.37 and its 200 day moving average is $138.42.

Agilent Technologies (NYSE:AGet Rating) last released its quarterly earnings results on Monday, November 21st. The medical research company reported $1.53 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.14. Agilent Technologies had a net margin of 18.31% and a return on equity of 30.28%. The business had revenue of $1.85 billion for the quarter, compared to analysts’ expectations of $1.76 billion. During the same period in the previous year, the company earned $1.21 earnings per share. The firm’s revenue for the quarter was up 11.4% compared to the same quarter last year. As a group, research analysts predict that Agilent Technologies, Inc. will post 5.64 earnings per share for the current fiscal year.

Agilent Technologies announced that its board has initiated a stock buyback program on Monday, January 9th that permits the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization permits the medical research company to repurchase up to 4.4% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s board of directors believes its stock is undervalued.

Agilent Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 25th. Shareholders of record on Tuesday, January 3rd will be given a $0.225 dividend. This represents a $0.90 dividend on an annualized basis and a yield of 0.58%. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.21. The ex-dividend date of this dividend is Friday, December 30th. Agilent Technologies’s dividend payout ratio is presently 21.58%.

Analyst Ratings Changes

A number of research firms have issued reports on A. KeyCorp lifted their target price on Agilent Technologies from $155.00 to $165.00 and gave the company an “overweight” rating in a research report on Tuesday, November 22nd. Citigroup boosted their price target on Agilent Technologies from $145.00 to $150.00 and gave the stock a “neutral” rating in a report on Tuesday, November 22nd. Wells Fargo & Company upgraded Agilent Technologies from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $150.00 to $170.00 in a report on Tuesday, January 10th. UBS Group upped their target price on Agilent Technologies from $152.00 to $170.00 and gave the company a “buy” rating in a report on Tuesday, December 20th. Finally, Cowen increased their price objective on shares of Agilent Technologies from $160.00 to $168.00 in a research report on Tuesday, November 22nd. Three investment analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $161.36.

About Agilent Technologies

(Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

Read More

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AGet Rating).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.